Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Summary of statements: In Europe at present, but also in 2040, 1 in 3 cancer-related deaths are expected to be caused by digestive cancers. Endoscopic technologies enable diagnosis, with relatively low invasiveness, of precancerous conditions and early cancers, thereby improving patient survival. Overall, endoscopy capacity must be adjusted to facilitate both effective screening programs and rigorous control of the quality assurance and surveillance systems required. 1 For average-risk populations, ESGE recommends the implementation of organized population-based screening programs for colorectal cancer, based on fecal immunochemical testing (FIT), targeting individuals, irrespective of gender, aged between 50 and 75 years. Depending on local factors, namely the adherence of the target population and availability of endoscopy services, primary screening by colonoscopy or sigmoidoscopy may also be recommendable. 2 In high-risk populations, endoscopic screening for gastric cancer should be considered for individuals aged more than 40 years. Its use in countries/regions with intermediate risk may be considered on the basis of local settings and availability of endoscopic resources. 3 For esophageal and pancreatic cancer, endoscopic screening may be considered only in high-risk individuals: – For squamous cell carcinoma, in those with a personal history of head/neck cancer, achalasia, or previous caustic injury; – For Barrett’s esophagus (BE)-associated adenocarcinoma, in those with long-standing gastroesophageal reflux disease symptoms (i. e., > 5 years) and multiple risk factors (age ≥ 50 years, white race, male sex, obesity, first-degree relative with BE or esophageal adenocarcinoma [EAC]). – For pancreatic cancer screening, endoscopic ultrasound may be used in selected high-risk patients such as those with a strong family history and/or genetic susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Correa, P. (1992) · PubMed · Cited by 3,216
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020 · cited 15×
“Other risk factors for conversion from BE to EAC are the presence of dysplasia or long-segment BE [63].”
BackgroundInfluentialRising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
Yeo, C. J., Cameron, J. L., Sohn, T. A., Lillemoe, K. D., Pitt, H. A., Talamini, M. A., Hruban, R. H., Ord, S. E., Sauter, P. K., Coleman, J., et al. (1997) · Annals of Surgery · doi:10.1097/00000658-199709000-00004 · Cited by 1,783
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623 · cited 1×
“The protective effects for those actually undergoing screening were 31% and 33% for incidence and 38% and 43% for mortality [11, 12].”
BackgroundDiagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study
Brugge, W. R., Lewandrowski, K., Lee-Lewandrowski, E., Centeno, B. A., Szydlo, T., Regan, S., del Castillo, C. F., & Warshaw, A. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.013 · Cited by 1,386 · cited 1×
“Moreover, in cystic lesions cytological investigation has low accuracy, and often the volume of cyst fluid aspirated from small cysts is low [111].”
BackgroundIncidence of Adenocarcinoma among Patients with Barrett's Esophagus
Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sørensen, H. T., & Funch-Jensen, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103042 · Cited by 1,371 · cited 2×
“In regions where the cancer incidence is lower, the usefulness of surveillance is questioned [60, 67].”
BackgroundFitzgerald, R. C., di Pietro, M., Ragunath, K., Ang, Y., Kang, J.-Y., Watson, P., Trudgill, N., Patel, P., Kaye, P. V., Sanders, S., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305372 · Cited by 1,346 · cited 3×
“, goblet cells) is a risk factor for evolution to neoplasia [63], and is a requirement for fulfilling the ESGE definition of BE.”
Background
Cited by
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Hassan, C., Antonelli, G., Dumonceau, J.-M., Regula, J., Bretthauer, M., Chaussade, S., Dekker, E., Ferlitsch, M., Gimeno-Garcia, A., Jover, R., et al. (2020) · Endoscopy · doi:10.1055/a-1185-3109 · Cited by 515
Self-citationDinis-Ribeiro, M., Libânio, D., Uchima, H., Spaander, M. C. W., Bornschein, J., Matysiak-Budnik, T., Tziatzios, G., Santos-Antunes, J., Areia, M., Chapelle, N., et al. (2025) · Endoscopy · doi:10.1055/a-2529-5025 · Cited by 193
Self-citationArtificial Intelligence Allows Leaving-In-Situ Colorectal Polyps
Hassan, C., Balsamo, G., Lorenzetti, R., Zullo, A., & Antonelli, G. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.04.045 · Cited by 119
Self-citationvan Bokhorst, Q. N., Houwen, B. B., Hazewinkel, Y., Fockens, P., & Dekker, E. (2023) · Endoscopy International Open · doi:10.1055/a-2098-1999 · Cited by 8
Self-citation
Metadata
- Authors
- Săftoiu, A., Hassan, C., Areia, M., Bhutani, M. S., Bisschops, R., Bories, E., Cazacu, I. M., Dekker, E., Deprez, P. H., Pereira, S. P., Senore, C., Capocaccia, R., Antonelli, G., van Hooft, J., Messmann, H., Siersema, P. D., Dinis-Ribeiro, M., & Ponchon, T.
- Venue
- Endoscopy
- Publisher
- Georg Thieme Verlag KG
- Published
- 2020-02-12
- Volume
- 52
- Issue
- 04
- Pages
- 293-304
- ISSN
- 0013-726X (ISSN-L)
- 1438-8812
- OpenAlex
- W3006619456
- Cited by
- 192
- References
- 101
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.